Showing results (1361-1370 of 1,507) with videos related to

Sort By:
Pageof 151
Genes and Immunity|August 26, 2011
The rs5743836 polymorphism in TLR9 confers a population-based increased risk of non-Hodgkin lymphomaA Carvalho, C Cunha, A J Almeida, et al.
Plos Neglected Tropical Diseases|January 31, 2019
Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivoCaroline S de Freitas, Luiza M Higa, Carolina Q Sacramento, et al.
Anais Da Academia Brasileira De Ciencias|April 22, 2026
Protective effect of latex proteins from Plumeria pudica against acetaminophen-induced acute liver injuryBruna DA Silva Souza, Ana Clara S Sales, Francisca Dayane S DA Silva, et al.
BMC Infectious Diseases|January 15, 2024
Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trialViravarn Luvira, William H K Schilling, Podjanee Jittamala, et al.
Lancet Regional Health. Americas|December 11, 2023
Recent HIV infection and annualized HIV incidence rates among sexual and gender minorities in Brazil and Peru (ImPrEP seroincidence study): a cross-sectional, multicenter studyThiago S Torres, Sylvia L M Teixeira, Brenda Hoagland, et al.
BMC Infectious Diseases|June 13, 2014
Streptococcus agalactiae in Brazil: serotype distribution, virulence determinants and antimicrobial susceptibilityVanusa G Dutra, Valéria M N Alves, André N Olendzki, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 13, 2024
The angiotensin-(1-7)/MasR axis improves pneumonia caused by Pseudomonas aeruginosa: Extending the therapeutic window for antibiotic therapyIsabella Zaidan, Antônio Felipe Silva Carvalho, Laís C Grossi, et al.
The Lancet. Infectious Diseases|October 1, 2023
Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trialWilliam H K Schilling, Podjanee Jittamala, James A Watson, et al.
The Journal of Infectious Diseases|July 20, 2023
Clinical Antiviral Efficacy of Remdesivir in Coronavirus Disease 2019: An Open-Label, Randomized Controlled Adaptive Platform Trial (PLATCOV)Podjanee Jittamala, William H K Schilling, James A Watson, et al.
Phytotherapy Research : PTR|March 18, 2025
Ouratein D, a Biflavanone From Ouratea spectabilis, Alleviates Betacoronavirus Infection by Mitigating Inflammation, Lung Damage and Viral ReplicationAdelson Héric A Monteiro, Kátia M Freitas, Ana Clara M Montuori-Andrade, et al.
Pageof 151